Phosphodiesterase 4 inhibitors for the treatment of asthma and COPD
about
Mdm2 directs the ubiquitination of beta-arrestin-sequestered cAMP phosphodiesterase-4D5Phosphodiesterase 4 inhibition enhances the dopamine D1 receptor/PKA/DARPP-32 signaling cascade in frontal cortex.Association between Psoriasis and Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysisStructures of the four subfamilies of phosphodiesterase-4 provide insight into the selectivity of their inhibitorsPivotal effects of phosphodiesterase inhibitors on myocyte contractility and viability in normal and ischemic hearts.Phosphodiesterase Inhibitors as a Therapeutic Approach to Neuroprotection and Repair.Distinct roles of adenylyl cyclase VII in regulating the immune responses in miceCigarette Smoke-Induced Emphysema and Pulmonary Hypertension Can Be Prevented by Phosphodiesterase 4 and 5 Inhibition in MiceAdministration of PDE4 inhibitors suppressed the pannus-like inflammation by inhibition of cytokine production by macrophages and synovial fibroblast proliferation.Update in chronic obstructive pulmonary disease 2006.Treating COPD with PDE 4 inhibitors.The analgesic effect of rolipram is associated with the inhibition of the activation of the spinal astrocytic JNK/CCL2 pathway in bone cancer pain.Further Insights in the Binding Mode of Selective Inhibitors to Human PDE4D Enzyme Combining Docking and Molecular Dynamics.Expression and activity of phosphodiesterase isoforms during epithelial mesenchymal transition: the role of phosphodiesterase 4.Epac and the high affinity rolipram binding conformer of PDE4 modulate neurite outgrowth and myelination using an in vitro spinal cord injury model.Advances in drug delivery: Is triple therapy the future for the treatment of chronic obstructive pulmonary disease?Computational determination of binding structures and free energies of phosphodiesterase-2 with benzo[1,4]diazepin-2-one derivatives.Design, synthesis, and structure-activity relationship, molecular modeling, and NMR studies of a series of phenyl alkyl ketones as highly potent and selective phosphodiesterase-4 inhibitors.Roflumilast increases Clara cell secretory protein in cigarette smoke-exposed mice.3D-QSAR Study of Potent Inhibitors of Phosphodiesterase-4 Using a CoMFA Approach.New insights into PDE4B inhibitor selectivity: CoMFA analyses and molecular docking studies.
P2860
Q24316484-7EFE4A3B-B6E6-45C1-BA17-0D775A82156AQ24633622-D07A83E3-0073-43B6-AC89-BFEFF7A5EAECQ26772143-485C6722-C7A5-46DA-8826-FB92A330C9DDQ27647620-F4CFB292-8E56-4B75-A3A7-08F2C38D476FQ33552229-E38E0EA3-247F-4EB9-8FA0-0964FE62FEF4Q33624262-AE8C6892-4925-4735-A6AF-B6FAB8EA2847Q34582255-37A26349-6086-467A-B660-F0DB68214493Q35658509-5CEB3659-F320-4434-A7D4-BEA581F419E5Q36445628-7DA826A3-9A2E-487D-86AC-C94778C6CE2DQ36838782-714F201B-4A1E-4C93-B3D1-B8AD33E34BCEQ37082594-AB7946CF-7157-4D99-9D0E-53A2C16BC8A0Q37341423-AE360123-0B54-493D-92D5-7AD0957A60AAQ37391836-78583AA1-A22A-4EAF-9E72-6D6585C1A632Q37420468-BAF93691-925F-409A-9225-1527CB7DB69EQ37719421-289F9EC7-6297-485F-9610-5CD98FBDE406Q37895710-080005BD-E1A3-4136-93DE-77729B837E47Q39817182-631548E4-6E52-4628-8FCB-DE560132FACFQ42002871-03C24C8C-8BDB-47EF-813B-2FA324EAEE7DQ43265548-1A1092FE-D2ED-400E-892F-3B9150FE513FQ46029687-A0159D1D-C135-43AC-8A6F-C3A5A2B61CE5Q48075432-82FD5417-13C7-41DF-85ED-EF6D3F1527E4
P2860
Phosphodiesterase 4 inhibitors for the treatment of asthma and COPD
description
2006 nî lūn-bûn
@nan
2006 թուականին հրատարակուած գիտական յօդուած
@hyw
2006 թվականին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Phosphodiesterase 4 inhibitors for the treatment of asthma and COPD
@ast
Phosphodiesterase 4 inhibitors for the treatment of asthma and COPD
@en
Phosphodiesterase 4 inhibitors for the treatment of asthma and COPD
@nl
type
label
Phosphodiesterase 4 inhibitors for the treatment of asthma and COPD
@ast
Phosphodiesterase 4 inhibitors for the treatment of asthma and COPD
@en
Phosphodiesterase 4 inhibitors for the treatment of asthma and COPD
@nl
prefLabel
Phosphodiesterase 4 inhibitors for the treatment of asthma and COPD
@ast
Phosphodiesterase 4 inhibitors for the treatment of asthma and COPD
@en
Phosphodiesterase 4 inhibitors for the treatment of asthma and COPD
@nl
P3181
P1476
Phosphodiesterase 4 inhibitors for the treatment of asthma and COPD
@en
P2093
Joseph A Mancini
Zheng Huang
P304
P3181
P356
10.2174/092986706778773040
P407
P577
2006-01-01T00:00:00Z